nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—PIM1—Ectoderm Differentiation—MAFB—cleft lip	0.0933	0.0933	CbGpPWpGaD
Mitoxantrone—PIM1—Ectoderm Differentiation—TFAP2A—cleft lip	0.0536	0.0536	CbGpPWpGaD
Mitoxantrone—ABCC1—Cobalamin (Cbl, vitamin B12) transport and metabolism—TCN2—cleft lip	0.0393	0.0393	CbGpPWpGaD
Mitoxantrone—ABCC1—ABC-family proteins mediated transport—ABCA4—cleft lip	0.0324	0.0324	CbGpPWpGaD
Mitoxantrone—ABCC1—Cobalamin (Cbl, vitamin B12) transport and metabolism—MTR—cleft lip	0.0272	0.0272	CbGpPWpGaD
Mitoxantrone—PIM1—Ectoderm Differentiation—SPRY2—cleft lip	0.0268	0.0268	CbGpPWpGaD
Mitoxantrone—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—TP63—cleft lip	0.0246	0.0246	CbGpPWpGaD
Mitoxantrone—PIM1—Ectoderm Differentiation—BMP4—cleft lip	0.0239	0.0239	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—BHMT2—cleft lip	0.0222	0.0222	CbGpPWpGaD
Mitoxantrone—CYP2E1—Folate-Alcohol and Cancer Pathway—MTHFR—cleft lip	0.0174	0.0174	CbGpPWpGaD
Mitoxantrone—ABCB1—ABC-family proteins mediated transport—ABCA4—cleft lip	0.0154	0.0154	CbGpPWpGaD
Mitoxantrone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—SLC19A1—cleft lip	0.0146	0.0146	CbGpPWpGaD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—ABCA4—cleft lip	0.0139	0.0139	CbGpPWpGaD
Mitoxantrone—PIM1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—cleft lip	0.0136	0.0136	CbGpPWpGaD
Mitoxantrone—PIM1—Ectoderm Differentiation—FGFR2—cleft lip	0.0133	0.0133	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—FGF7—cleft lip	0.0126	0.0126	CbGpPWpGaD
Mitoxantrone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—TCN2—cleft lip	0.0121	0.0121	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—FGF7—cleft lip	0.0119	0.0119	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—FGF7—cleft lip	0.0119	0.0119	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—FGF8—cleft lip	0.0116	0.0116	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—FGF7—cleft lip	0.011	0.011	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—FGF8—cleft lip	0.0109	0.0109	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—FGF8—cleft lip	0.0109	0.0109	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—FGF8—cleft lip	0.0101	0.0101	CbGpPWpGaD
Mitoxantrone—ABCG2—Fluoropyrimidine Activity—TYMS—cleft lip	0.00983	0.00983	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—FGF3—cleft lip	0.00947	0.00947	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	0.00933	0.00933	CbGpPWpGaD
Mitoxantrone—PIM1—Validated targets of C-MYC transcriptional activation—MYC—cleft lip	0.00925	0.00925	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—FGF9—cleft lip	0.00923	0.00923	CbGpPWpGaD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00899	0.00899	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—FGF3—cleft lip	0.00891	0.00891	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—FGF3—cleft lip	0.00891	0.00891	CbGpPWpGaD
Mitoxantrone—PIM1—C-MYB transcription factor network—MYC—cleft lip	0.00881	0.00881	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—FGF9—cleft lip	0.00869	0.00869	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—FGF9—cleft lip	0.00869	0.00869	CbGpPWpGaD
Mitoxantrone—BTK—IL-5 Signaling Pathway—MYC—cleft lip	0.0086	0.0086	CbGpPWpGaD
Mitoxantrone—ABCG2—Fluoropyrimidine Activity—MTHFR—cleft lip	0.00859	0.00859	CbGpPWpGaD
Mitoxantrone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTR—cleft lip	0.0084	0.0084	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—FGF3—cleft lip	0.00824	0.00824	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—FGF9—cleft lip	0.00804	0.00804	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—FGF10—cleft lip	0.00779	0.00779	CbGpPWpGaD
Mitoxantrone—BTK—TSLP Signaling Pathway—MYC—cleft lip	0.00756	0.00756	CbGpPWpGaD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—cleft lip	0.00743	0.00743	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—FGF10—cleft lip	0.00733	0.00733	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—FGF10—cleft lip	0.00733	0.00733	CbGpPWpGaD
Mitoxantrone—TOP2A—Gastric Cancer Network 2—MYC—cleft lip	0.00685	0.00685	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—FGF10—cleft lip	0.00678	0.00678	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—FGFR2—cleft lip	0.00625	0.00625	CbGpPWpGaD
Mitoxantrone—PIM1—Ectoderm Differentiation—MYC—cleft lip	0.00592	0.00592	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—FGFR2—cleft lip	0.00588	0.00588	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—FGFR2—cleft lip	0.00588	0.00588	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—FGFR1—cleft lip	0.00582	0.00582	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—FGFR3—cleft lip	0.0055	0.0055	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—FGFR1—cleft lip	0.00548	0.00548	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—FGFR1—cleft lip	0.00548	0.00548	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—FGFR2—cleft lip	0.00544	0.00544	CbGpPWpGaD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—TYMS—cleft lip	0.00523	0.00523	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—FGFR3—cleft lip	0.00518	0.00518	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—FGFR3—cleft lip	0.00518	0.00518	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—FGFR1—cleft lip	0.00507	0.00507	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—FGFR3—cleft lip	0.00479	0.00479	CbGpPWpGaD
Mitoxantrone—CYP1B1—Biological oxidations—MTR—cleft lip	0.00471	0.00471	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—FGF7—cleft lip	0.00461	0.00461	CbGpPWpGaD
Mitoxantrone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cleft lip	0.0045	0.0045	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—FGF7—cleft lip	0.00442	0.00442	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IRF6—cleft lip	0.00428	0.00428	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—FGF2—cleft lip	0.00425	0.00425	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—FGF8—cleft lip	0.00425	0.00425	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Receptor Signaling Pathway—MYC—cleft lip	0.00423	0.00423	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—FGF8—cleft lip	0.00408	0.00408	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—FGF2—cleft lip	0.004	0.004	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—FGF2—cleft lip	0.004	0.004	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.00396	0.00396	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—TYMS—cleft lip	0.0038	0.0038	CbGpPWpGaD
Mitoxantrone—BTK—B Cell Activation—FGF2—cleft lip	0.0037	0.0037	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—FGF3—cleft lip	0.00346	0.00346	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00338	0.00338	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—FGF9—cleft lip	0.00337	0.00337	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.00335	0.00335	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—MYC—cleft lip	0.00335	0.00335	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—FGF3—cleft lip	0.00332	0.00332	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—FGF9—cleft lip	0.00324	0.00324	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—MTR—cleft lip	0.00307	0.00307	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—NODAL—cleft lip	0.00307	0.00307	CbGpPWpGaD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—MYC—cleft lip	0.003	0.003	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00298	0.00298	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—SUMO1—cleft lip	0.00293	0.00293	CbGpPWpGaD
Mitoxantrone—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—cleft lip	0.00289	0.00289	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—FGF10—cleft lip	0.00285	0.00285	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—FGF10—cleft lip	0.00273	0.00273	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FGF7—cleft lip	0.00268	0.00268	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FGF8—cleft lip	0.00248	0.00248	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.00245	0.00245	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—FGFR2—cleft lip	0.00228	0.00228	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—FGFR2—cleft lip	0.00219	0.00219	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—FGFR1—cleft lip	0.00213	0.00213	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—WNT9B—cleft lip	0.00212	0.00212	CbGpPWpGaD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—MYC—cleft lip	0.00211	0.00211	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—FGFR1—cleft lip	0.00204	0.00204	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FGF3—cleft lip	0.00202	0.00202	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—FGFR3—cleft lip	0.00201	0.00201	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FGF9—cleft lip	0.00197	0.00197	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—FGFR3—cleft lip	0.00193	0.00193	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—TYMS—cleft lip	0.00192	0.00192	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—ABCA4—cleft lip	0.00189	0.00189	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SLC19A1—cleft lip	0.00173	0.00173	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—TYMS—cleft lip	0.00172	0.00172	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—WNT3—cleft lip	0.00169	0.00169	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FGF10—cleft lip	0.00166	0.00166	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—ABCA4—cleft lip	0.00161	0.00161	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.0016	0.0016	CbGpPWpGaD
Mitoxantrone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—cleft lip	0.00156	0.00156	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—FGF2—cleft lip	0.00155	0.00155	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—FGF2—cleft lip	0.00149	0.00149	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SLC19A1—cleft lip	0.00145	0.00145	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TCN2—cleft lip	0.00143	0.00143	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—MTR—cleft lip	0.00143	0.00143	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SLC19A1—cleft lip	0.0014	0.0014	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FGFR2—cleft lip	0.00133	0.00133	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—cleft lip	0.0013	0.0013	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SLC19A1—cleft lip	0.00128	0.00128	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FGFR1—cleft lip	0.00124	0.00124	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—TCN2—cleft lip	0.0012	0.0012	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FGFR3—cleft lip	0.00117	0.00117	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—TCN2—cleft lip	0.00116	0.00116	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SPRY2—cleft lip	0.00111	0.00111	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGF7—cleft lip	0.00111	0.00111	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—cleft lip	0.0011	0.0011	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TCN2—cleft lip	0.00106	0.00106	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGF8—cleft lip	0.00103	0.00103	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTR—cleft lip	0.000994	0.000994	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC19A1—cleft lip	0.000915	0.000915	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FGF2—cleft lip	0.000906	0.000906	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGF3—cleft lip	0.000838	0.000838	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MTR—cleft lip	0.000832	0.000832	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGF9—cleft lip	0.000817	0.000817	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—cleft lip	0.000806	0.000806	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MTR—cleft lip	0.000805	0.000805	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—MYC—cleft lip	0.000775	0.000775	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TCN2—cleft lip	0.000759	0.000759	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MTR—cleft lip	0.000732	0.000732	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—MYC—cleft lip	0.000693	0.000693	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC19A1—cleft lip	0.000689	0.000689	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGF10—cleft lip	0.000689	0.000689	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TCN2—cleft lip	0.000571	0.000571	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGFR2—cleft lip	0.000553	0.000553	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTHFR—cleft lip	0.000532	0.000532	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—cleft lip	0.000527	0.000527	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MTR—cleft lip	0.000526	0.000526	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGFR1—cleft lip	0.000515	0.000515	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—TYMS—cleft lip	0.00051	0.00051	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—TYMS—cleft lip	0.000493	0.000493	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGFR3—cleft lip	0.000487	0.000487	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TYMS—cleft lip	0.000449	0.000449	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MTHFR—cleft lip	0.000446	0.000446	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MTHFR—cleft lip	0.000431	0.000431	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC19A1—cleft lip	0.000425	0.000425	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTR—cleft lip	0.000396	0.000396	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MTHFR—cleft lip	0.000392	0.000392	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGF2—cleft lip	0.000376	0.000376	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS3—cleft lip	0.000371	0.000371	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TCN2—cleft lip	0.000352	0.000352	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TYMS—cleft lip	0.000322	0.000322	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NOS3—cleft lip	0.000311	0.000311	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NOS3—cleft lip	0.000301	0.000301	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MTHFR—cleft lip	0.000282	0.000282	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NOS3—cleft lip	0.000273	0.000273	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MYC—cleft lip	0.000246	0.000246	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTR—cleft lip	0.000244	0.000244	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TYMS—cleft lip	0.000243	0.000243	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTHFR—cleft lip	0.000212	0.000212	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NOS3—cleft lip	0.000196	0.000196	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TYMS—cleft lip	0.00015	0.00015	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NOS3—cleft lip	0.000148	0.000148	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTHFR—cleft lip	0.000131	0.000131	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NOS3—cleft lip	9.11e-05	9.11e-05	CbGpPWpGaD
